Roxithromycin is a semi-synthetic macrolide antibiotic precursor derived from erythromycin. It shares the same 14-membered lactone ring structure as erythromycin, with an oxime-based side chain attached to the macrolide ring.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 111321-02-9
Clarithromycin oxime
pharmaceutical intermediate
PUBCHEM_71314812
pharmaceutical research compound
Roxithromycin
pharmaceutical raw material
Zileuton
pharmaceutical raw material
Ponatinib hydrochloride
pharmaceutical raw material
Amlodipine besylate
pharmaceutical raw material
Metformin hydrochloride
pharmaceutical raw material
Erythromycin oxime
pharmaceutical raw material
(3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-10-hydroxyimino-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one
KYTWXIARANQMCA-ZTILBQITSA-N
CC[C@@H]1[C@@]([C@@H]([C@H](/C(=N/O)/[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O